The Insight–Adherence–Abstinence triad: An integrated treatment focus for cannabis-using first–episode schizophrenia patients
Bulletin of the Menninger Clinic · 2005
DOI: 10.1521/bumc.2005.69.3.220 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bulletin of the Menninger Clinic, 2005. Verfasst von Rachel Miller und 3 weiteren Autor:innen. Beteiligte Einrichtung: Research Department, The Zucker Hillside Hospital/NSLIJ, Glen Oaks, New York 11004, USA. rmiller@lij.edu. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: NIMH NIH HHS, NCRR NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Research Department, The Zucker Hillside Hospital/NSLIJ, Glen Oaks, New York 11004, USA. rmiller@lij.edu
Förderung
- NIMH NIH HHS
- NCRR NIH HHS
Zitieren
APA
Miller, R., Caponi, J. M., Sevy, S., & Robinson, D. (2005). The Insight–Adherence–Abstinence triad: An integrated treatment focus for cannabis-using first–episode schizophrenia patients. Bulletin of the Menninger Clinic. https://doi.org/10.1521/bumc.2005.69.3.220
Vancouver
Miller R, Caponi JM, Sevy S, Robinson D. The Insight–Adherence–Abstinence triad: An integrated treatment focus for cannabis-using first–episode schizophrenia patients. Bulletin of the Menninger Clinic. 2005. doi:10.1521/bumc.2005.69.3.220
BibTeX
@article{Miller2005,
author = {Miller, Rachel and Caponi, Joanne McCormack and Sevy, Serge and Robinson, Delbert},
title = {The Insight–Adherence–Abstinence triad: An integrated treatment focus for cannabis-using first–episode schizophrenia patients},
journal = {Bulletin of the Menninger Clinic},
year = {2005},
doi = {10.1521/bumc.2005.69.3.220}
}
EUVIMED